Molecular Characterization of Pasteurella multocidaVaccine  Strains by Badawi, Hajir
ﻢﻴﺣﺮﻟا ﻦﻤﺣﺮﻟا ﷲا ﻢﺴﺑ 
  
Molecular Characterization of Pasteurella multocida Vaccine 
Strains 
 
By: 
Hajir Badawi Mohammed Ahmed 
B.V.M Khartoum University (2006) 
 
Supervisor: 
Dr. Awad A. Ibrahim 
A dissertation submitted to the University of Khartoum in partial 
fulfillment of the requirements for the degree of M. Sc. in 
Microbiology 
 
Department of Microbiology, 
Faculty of Veterinary Medicine, 
University of Khartoum 
 
 
June, 2010 
  
 
Dedication 
 
 
To my mother 
Father 
Brother, sister and friends 
With great love 
 Acknowledgments 
First and foremost, I would like to thank my 
Merciful Allah, the most beneficent for giving me 
strength and health to accomplish this work. 
Then I would like to deeply thank my supervisor Dr. 
Awad A. Ibrahim for his advice, continuous 
encouragement and patience throughout the period 
of this work. 
My gratitude is also extended to prof. Mawia M. 
Mukhtar and for Dr. Manal Gamal El-dein, Institute 
of Endemic Disease.  
My thanks extend to members of Department of 
Microbiology Faculty of Veterinary Medicine for 
unlimited assistant and for staff of Central 
Laboratory Soba.   
 I am grateful to my family for their continuous 
support and standing beside me all times.  
 My thanks also extended to all whom I didn’t 
mention by name and to the forbearance of my 
friends, and colleagues who helped me. 
Finally I am indebted to all those who helped me so 
much to make this work a success. 
 Abstract 
The present study was carried out to study the national haemorrhagic 
septicaemia vaccine strains at their molecular level. The vaccine is 
bivalent contain Pasteurella multocida serotype E:2 and B:2. The 
vaccine strains were obtained from Central Veterinary Research 
Laboratory, Department of Biological Product, Soba. Culture 
characteristic and colonial morphology was ascertained in common 
laboratory media. The bacterial strains were characterized by using 
sodium-dodecyl sulphate polyacrylamide gel electrophoresis SDS-
PAGE, western blotting and by using PCR for capsular serotyping.  
Firstly, the two strains were characterized by SDS-PAGE technique. 
The bacteria were cultured in liquid media, and then the bacterial 
whole cell lysates were prepared. SDS-PAGE was carried out for both 
strains and the proteins bands were stained with coomassie brilliant 
blue. Then the molecular weights of the proteins bands were 
determined; they were 175 kDa, 165 kDa, 150 kDa, 123 kDa, 102kDa, 
90 kDa, 85 kDa, 70 kDa, 64 kDa, 60 kDa, 51 kDa, 42 kDa, 37 kDa, 22 
kDa and16 kDa. The protein profiles of both vaccine strains were 
similar.  
P. multocida strains protein profiles were investigated by 
immunoblotting using specific hyperimmune sera prepared in rabbits. 
Immunostaining with enzyme conjugate was done after transfer of 
proteins in nitrocellulose acetate paper. Eight proteins in whole cell 
lysate, of approximately 175 kDa, 102 kDa, 90 kDa, 85 kDa, 70 kDa, 
42kDa, 37 kDa, and 16 kDa, were recognized by the sera. 
 The PCR assay was performed for strain B and E of P. multocida by 
using primers that amplify capsule gene. Two extraction methods for 
DNA were used. There were the Boiling method and the kits method 
in which a lysis buffer is used. The two methods of DNA extraction 
gave good DNA yield. However the kit method was better in this 
respect than the boiling method. Primers of strain E gave an 
amplification product of 511 bp for vaccine strain E. In contrast 
primers of strain B did not amplify strain B DNA vaccine strain but 
amplified strain B field strain which were obtained from Department 
of Microbiology Faculty of Veterinary Medicine, University of 
Khartoum stock culture and the amplicon was 760 bp.  
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 Introduction 
Haemorrhagic septicaemia (HS) is a major disease of cattle and 
buffaloes characterized by an acute, highly fatal septicaemia with high 
morbidity and mortality (Bain et al., 1982; Carter and De Alwis, 1989; 
Mustafa et al, 1978). The disease has been recorded in wild mammals 
in several Asian and European countries (Carigan et al, 1991).  
Outbreaks mostly occur during change in the climatic conditions, as 
high humidity and high temperatures.  
 
The disease is caused by P. multocida, a Gram-negative coccobacillus 
residing mostly as commensal bacteria in the upper respiratory tract of 
animals. The Asian serotype B:2 and the African serotype E:2 (Carter 
and Heddleston system) (Carter, 1955; Heddleston et al., 1972) 
corresponding to 6:B and 6:E (Namioka-Carter system) (Namioka and 
Bruner, 1963), are mainly responsible for the disease. 
 
Haemorrhagic septicaemia occurs in Africa, Asia, Central, South 
America and Europe. The disease was also reported in Sudan and 
serotypes E and B were isolated (Shigidi and Mustafa, 1979). The 
clinical manifestations of the typical disease caused by B:2 or E:2 
strains include a rise in temperature, respiratory distress with nasal 
discharge, and frothing from the mouth, followed by recumbency and 
death. In the recent past, HS has been identified as a secondary 
complication in cattle and buffalos following outbreaks of foot and 
mouth disease (FMD) (De Alwis, 1992; Carter and De Alwis, 1989). 
 
 Vaccination is considered an effective mean of controlling this 
disease. Local isolates are usually used for vaccine preparation. In 
haemorrhagic septicaemia, capsular antigen, LPS or LPS-protein 
complex, and outer membrane proteins, including the iron-regulated 
outer membrane proteins are effective immunogens for serogroups B 
and E (Carter and De Alwis, 1989). However, no published report is 
written for immunogenic proteins of P. multocida that cause 
haemorrahgic septicaemia in Sudan. Vaccinations with inactivated 
whole-cell preparations posses the problem that they do not provide 
long-lasting immunity (Verma and Jaiswal, 1998; De Alwis, 1999). 
The key antigens of P. multocida B:2 that evoke protective immunity 
to HS in cattle have been defined and P. multocida B:2 outer-
membrane proteins (OMPs) have been implicated as protective 
antigens (Vasfri and Mittal, 1997; Srivastava, 1998). For other 
serotypes of P. multocida, OMPs are recognized as important 
immunogens. Several OMPs are immunogens and the antibodies 
produced against these OMPs demonstrate a strong protective action, 
such antigens may be used as a component of subunit vaccines 
(Rimier, 2001; Gatto et al., 2002; Prado et al., 2005).   
P.multocida is characterized serologically by identification of 
capsular antigens by using passive haemagglutination test and by 
detection somatic antigens using gel diffusion tests. Serotyping of 
P.multocida is currently only undertaken by regional reference 
laboratories (Carter, 1955). Five serogroups A, B, D, E and F are 
currently distinguished in the Carter system. A limitation of the 
capsule typing is the difficulty in inducing antibodies to specific 
antigens. Most workers found it relatively easy to induce antibodies 
 against B and E serogroup specific antigens, but not the other 
serogroup specific antigens.  In many instances a non-encapsulated 
strain is found to be unserotypeable (Rimier and Rhoades, 1989). A 
multiplex Polymerase Chain Reaction was introduced as a rapid 
alternative to capsular serotyping system (Townsend et al., 2001). 
using this technique, however only the capsular serotying information 
could be ascertained; this are helping in serotyping instead of the 
conventional method of serotyping. 
 
Objective of the study: 
- To determine the protein profiles of Pasteurella multocida by 
SDS PAGE. 
- To detect immunogenic proteins of Pasteurella multocida 
strains used in vaccine production by immunoblotting. 
- To determine the efficacy of PCR using capsule gene primers in 
compared with serotyping in the study of P. multocida. 
 
 
 
 
 
 
 
 
 
 
 
 CHAPTER ONE 
LITERATURE REVIEW 
 
1.1 Haemorrhagic septicaemia  
Haemorrhagic septicemia is an acute, highly fatal septicaemic disease of 
cattle and buffaloes, characterized by fatal septicaemia with high 
morbidity and mortality. The symptoms progress rapidly from dullness 
and fever to death within hours and recovery is rare (Carter, 1967). 
 
1.2 Etiology 
Haemorrhagic septicaemia is caused by specific serotypes within the 
bacterial species of P. multocida; more frequently by two specific 
serotypes of P. multocida, serotype B:2 and E:2 in Asia and Africa, 
respectively (Carter, 1955; Heddleston et al., 1972). These serotypes are 
corresponding to the newer 6:B and 6:E classification i.e Namioka-
Carter system (Namioka and Bruner, 1963). In this respect a few 
countries such as Egypt and Sudan, have recorded both serotypes (Farid 
et al., 1980; Shigidi and Mustafa, 1979). 
P. multocida is a Gram-negative bacterial pathogen which is the 
causative agent of a range of diseases in animals, including fowl cholera 
in avian species (Carter, 1972), haemorrhagic septicaemia in ungulates 
(De Alwis, 1984), atrophic rhinitis in swine (White et al., 1993), and 
snuffles in Rabbit (Manning, 1984). This bacterium also causes infection 
in humans; primarily through dog and cat bites (Talan, 1999). 
 
 
 1.3 Taxonomy 
 The classification of Pasteurella multocida is: 
Kingdom:Bacteria. 
Phylum:Proteobacteria. 
Class:GammaProteobacteria. 
Order:Pasteurellales. 
Family: Pasteurellaceae. 
The family Pasteurellaceae contains genera Actinobacillus, 
Haemophilus, Lonepinella, Mannheimia and Phocoenobacter. This 
taxonomy is based on outer membrane proteins (OMPs) for iron 
acquisitions have roles in infection and pathogenesis. Characterization of 
cell surface proteins of members of the Pasteurellaceae family including 
Haemophilus, Actinobacillus, Pasteurella, and the Mannheimia genera of 
organisms has highlighted several redundant iron acquisition receptors 
for transferrin, siderophores, and heme/heme-containing protein (Chung 
et al., 2008).  More taxanomy was done on the basis of the 16r RNA 
sequencing and phylogentic analysis (Dewhirst et al., 1992). 
1.4 Morphological, biochemical and cultural characteristic 
P. multocida is a small, Gram negative coccobacillary rod, with bipolar 
staining characteristics from tissues, nonmotile, non-spore forming and 
non-haemolytic, aerobic to facultative anaerobic and produce indole and 
ferment carbohydrates with slight gas production (Quinn et al., 1994). 
1.5 Phenotypic and genotypic characterization 
Phenotypic characterization is based on the bacterium biochemical 
reaction where, dulcitol and sorbitol fermentation method is argued. 
There were significant variations in the phenotypic properties of P. 
 multocida they have been reported (Heddleston, 1976). Mutters, et al. 
(1985) reclassified genotypically as members of the genus Pasteurella on 
the basis of DNA-DNA hybridization studies. Three clusters of P. 
multocida showing 84 to 100, 91 to 100, and 89 to 100% DNA 
reassociation between strains. There were subsequently classified as P. 
multocida subsp. multocida, P. multocida subsp. gallicida, and P. 
multocida subsp. septica. Representatives of the existing capsular types 
were found to be closely related on the basis of DNA-DNA hybridization 
(Pohl, 1981), despite the diversity of disease manifestations and hosts. 
Further, the study of Kuhnert, et al (2000) also showed that variant 
phenotypes of P. multocida shared at least 98.5% 16S rRNA sequence 
similarity with the recognized subspecies of this species. 
1.6 Epidemiology 
Haemorrhagic septicaemia (HS) is an endemic disease in most countries 
of Asia and sub-Saharan Africa. Within the Asian Region, countries can 
be classified into three categories, on the basis of incidence and 
distribution of the disease. These are respectively countries where the 
disease is endemic or sporadic, clinically suspected but not confirmed, or 
free. Economic losses due to HS are confined to losses in animal 
industry. Only a few attempts have been made to estimate economic 
losses (Dutta et al., 1990). 
Organism causing HS does not survive outside the animal body to any 
significant degree to be a source of infection. Moist conditions prolong 
its survival. Thus the disease tends to spread more during the wet season. 
Also movements of animals, work stress in work animals, levels of low 
nutrition etc. all of which favour the precipitation of outbreaks 
(Benkirane and De Alwis, 2002). 
 1.6.1Transmission 
Infection occurs by inhalation or ingestion of P. multocida bacteria. 
Higher incidence of HS is associated with moist, humid conditions, high 
animals population density, and extensive free grazing system of 
management, where large herds graze freely in common pastures 
(Benkirane and De Alwis, 2002).  
 
1.6.2 Mortality and morbidity 
In situations where occasional sporadic outbreaks occur in some regions 
within endemic countries, mortality may be very high unlike in endemic 
areas where regular, seasonal outbreaks occur, where losses in each 
outbreak are low and confined to young animals. The phenomenon of 
naturally acquired immunity resulting from the so-called non-fatal 
infection largely controls the mortality and morbidity patterns 
(Benkirane and De Alwis, 2002). 
 
1.6.3 Host range 
Cattle and water buffaloes are the principal hosts of hemorrhagic 
septicemia (De Alwis, 1984) and it is widely considered that buffaloes 
are the more susceptible. Outbreaks of hemorrhagic septicemia have 
been reported in sheep and swine where it is not a frequent or 
significant disease. Cases have been reported in deer, elephants and 
yaks. There is as yet no evidence of a reservoir of infection outside the 
principal hosts; there are cattle, water buffaloes, and bison (Heddleston 
and Gallagher, 1969). The disease was reported in camels in Sudan in 
Blue Nile Province and the causative agent was identified to be 
serotype B:6 (Hassan and Mustafa, 1985). 
 
 1.6.4 Geographic distribution 
Occurrences of the disease in certain parts of the world like Southeast 
Asia, where favourable conditions often coincide, are the area of 
highest incidence. The disease occurs in the Middle East and Africa 
where the environmental circumstances and predisposing conditions are 
not as clearly defined as in Southeast Asia. In Asia, the disease is 
frequently associated with the rainy season and poor physical condition 
(De Alwis, 1984) 
Haemorrhagic septicaemia was recognized in Japan as a specific 
disease of cattle caused by particular strains of pasteurella as early as 
1923. Since 1926, the disease has been controlled, and the last recorded 
case in cattle in Japan occurred In 1952.The B:2 serotype has been 
recovered from haemorrhagic septicaemia in countries of Southern 
Europe, the Middle East, and South East Asia, including China 
(Anonymous, 1991). This same serotype has been reported from Egypt 
and the Sudan. The E:2 serotype has been recovered from hemorrhagic 
septicemia occurring in Egypt , Sudan, the Republic of south Africa, 
and several other African countries. There is no report of either 
serotype being recovered from Australia, New Zealand, and countries 
of South and Central America. There is no evidence that the disease has 
spread from carrier bison in the western United States to neighboring 
cattle. Given the conditions in which hemorrhagic Septicemia occurs in 
endemic areas where primitive husbandry practices, low country plains, 
and well-defined dry and wet seasons, it seems unlikely that the disease 
will reach epidemic proportions in the United States (De Alwis, 1984). 
 
The disease was reported in Sudan in Blue Nile, Kassala Nothern 
Kordofan, and Upper Nile Province. The serotypes B:6 and E:6 were 
 isolated and identified from cases of Haemorrahagic septicaemia in cattle 
by Shigidi and Mustafa, (1979).  
 
1.7 Antigenic structure and serotyping 
Early attempts at serological classification of P. multocida date back to 
the 1920. Agglutination absorption test has identified Groups I, II, III 
and IV (Cornelius, 1929), whereas Yusef, (1935) used precipitation test 
to identify Groups I, II, III and IV. Rosenbach and Merchant, (1939) 
used agglutination fermentation identified Groups I, II and III. Little and 
Lyon, (1943) used slide agglutination and identified Types 1, 2 and 3. 
However, Roberts, (1947) developed a system of serological 
classification based on passive protection tests in mice. He used antisera 
prepared in rabbits to protect mice against challenge with a wide range 
of strains. On the basis of mouse protection, he was able to identify four 
types, which he designated types I, II, III and IV. This was the first 
classification to meet some degree of acceptance. Since all HS strains 
fell into Roberts's type I, this designation became fairly well established. 
Lately, Hudson, (1954) added a fifth serotype.  
 
Carter used a precipitation test (Carter, 1952) and subsequently, an 
indirect haemagglutination test (Carter, 1955) was able to identify four 
serological types. These were based on agglutination of human type O 
erythrocytes coated with crude extracts of outer cell components from 
the bacterial cultures. These crude capsular extracts supernatants were 
prepared by heating suspensions of the bacteria at 56°C for 30 minutes 
and removing the cells by centrifugation. He designated these four 
capsular types A, B, C and D (Carter1952, 1955). The strains that caused 
HS were grouped into Carter type B. Subsequently, he found that the 
 strains that caused HS in Africa did not fall strictly into any of these 
groups, though they were related to type B, and they were included in a 
separate group designated type E (Carter, 1961). Later, he found that 
type C was not a consistent type and it was deleted (Carter, 1963). This 
method of identifying serotypes has become established as the Carter 
indirect haemagglutination test (IHA). 
 
Three decades later, Rimier and Rhoades, (1987) isolated a consistent 
type from turkeys which did not fit into any existing serogroups, this was 
designated serogroup F. Since fresh human type O erythrocytes may not 
always be available in a laboratory, the IHA test has been modified by 
various workers for practical convenience. Carter and Rappay, (1962) 
used formalinised human type O cells, which could be stored in a 
laboratory for long periods. More recently, Sawada et al. (1982) used 
glutaraldehyde-fixed sheep erythrocytes. The test has now been modified 
for the detection of antibodies as well, using erythrocytes coated with 
cell extracts from known reference cultures. Wijewardana et al. (1986) 
used fresh sheep erythrocytes, and adopted the test both for identification 
of serotype and for antibody detection. Namioka and Murata, (1961 a) 
described a simplified and rapid method of identifying the capsular types 
using a slide agglutination test in which fresh cultures are agglutinated 
with hyperimmune rabbit sera. Namioka and Murata, (1964) and 
Namioka and Bruner, (1963) developed what is described as a somatic 
typing test, based on releasing core (somatic) bacterial components by 
agglutinating acid (HCI)-treated cells with rabbit antiserum. Using this 
method, 11 somatic types were identified. Type-specific antiserum was 
produced by a complicated system of absorptions. Another drawback to 
this system is that some cultures undergo auto agglutination after the 
 HCI treatment and therefore are rendered untypeable. Heddleston et al. 
(1972) developed an agar gel precipitation test also for somatic typing. 
In this test, the antigen used was the supernatant of culture suspensions 
heated at 100°C for one hour. The antiserum was prepared in chicken. 
Using this method, 16 different somatic types were recognized. This test 
was originally used to type avian strains from fowl cholera but is now 
extended to strains from all host species. 
 
1.7.1Designation of serotypes 
Currently, the most acceptable and widely used serotype designation 
system is a combination of Carter capsular typing and Heddleston 
somatic typing. Using this method, the Asian and African HS serotypes 
are designated B:2 and E:2 and a non-HS type B strain of Australian 
origin as B:3,4. This strain was originally isolated from a bovine wound 
but has subsequently been associated with occasional HS-like 
septicaemic disease in cattle in North America and deer in the United 
Kindom . Since there are only two of Namioka's types (6 and 11) among 
the capsular type B strains, and only one (6) among the capsular type E 
strains, a combination of capsular and Namioka typing is also used 
occasionally (i.e. 6:B and 6:E for the Asian and African strains). Under 
this system, the avirulent Australian strain is designated 11:B. Since both 
systems are used in the literature. 
  
In the Carter-Heddleston system, the capsular type is expressed first, 
followed by the somatic type. In the Namioka-Carter system, expression 
is made in the reverse order. Broadly, two typing systems are adopted. 
One is the capsular typing by Carter’s IHA test (Carter, 1955) or by 
AGID tests (Anon, 1981; Wijewardena, 1982). The other is somatic 
 typing by the method Of Namioka and Murata (Namioka, 1978; 
Namioka and Murata, 1961b) and by the method of (Heddleston, et al. 
1972). It is generally agreed that designation of serotypes should be 
based on a somatic– capsular combination. 
 
1.8 Pathogenesis 
Upon entry of the Pasteurella organism into the animal, it is believed that 
the initial site of multiplication is the tonsillar region. The outcome of 
this infection depends on an interaction between the virulence of the 
organism and its rate of multiplication in vivo, and the specific immune 
mechanisms and nonspecific resistance factors of the host animal. Thus, 
the dose of infection is a vital factor and if the organism overcomes the 
host's defence mechanisms, clinical disease will result. If the defence 
mechanisms dominate over the organism, this is described as an arrested 
infection and the animal becomes an immune carrier. Such animals 
possess solid immunity, and the presence of large numbers of such 
immune animals following an outbreak of disease contributes to 'herd 
immunity' (De Alwis et al., 1986). 
 
1.8.1Lipopolysaccaride (LPS) 
The LPS of P. multocida are similar to those of other gram-negative 
bacteria. They constitute the endotoxins of the organism, and are the 
basis of somatic typing. LPS are largely responsible for the toxicity in 
the HS causing serogroup B:2, and play an important role in the 
pathogenesis of the disease (Rebers et al., 1967). Purified LPS extracts 
have been shown to have antiphagocytic activity in vitro by using 
phagocytic uptake assays in an ovine mammary neutrophil system and 
[3H] labeled type B strain of P. multocida. Muniandy et al. (1993) found 
 that capsular polysaccharide extracts known to contain 20% 
lipopolysaccharides (LPS), potassium thiocyante extracts and Westphal 
type LPS extracts inhibited phagocytosis. These workers also found that 
when encapsulated cells and de-encapsulated cells were used, the 
percentage of de-encapsulated cells phagocytosed was significantly 
higher than when encapsulated cells of P. multocida were used. These 
observations indicated that HS-causing strains of P. multocida appeared 
to possess a factor in their capsule that inhibited the ability of phagocytes 
to engulf and destroy invading bacterial cells. It is well established that 
the endotoxins of gram negative bacteria consist predominantly of LPS. 
The toxic effects of the LPS of P. multocida associated with HS have 
been demonstrated, where it produced experimental HS in calves and 
pigs by different routes using type B strains. Also administered 
endotoxin prepared from this strain to a calf induced symptoms and 
lesions resembled those of experimental infection (Rebers et al., 1967). 
 
1.8.2Capsule 
 Dissociation of colonies is associated with reduction or loss of virulence 
and also with loss of antigenicity. Well capsulated cultures make good 
vaccines; for this reason, vaccine seed cultures are passaged in 
laboratory animals or even in natural host species periodically. However, 
the relationship between the capsule and virulence is not absolute. There 
are capsulated variant cultures that are of low virulence or are avirulent, 
while non capsulated strains may be virulent (Wijewardana et al., 1986). 
 
 
 
 
 1.8.2 Enzyme 
P. multocida has been found to produce a number of enzymes. 
Neuraminidase is produced by members of serogroups A, B, D and E 
(Rimier and Rhoades, 1989). Its activity  is found to be highest in strains 
of serogroup A and D. Activity of neuraminidase of type E was inhibited 
by homologous antiserum only, while those of types B and D were 
inhibited by antisera against serogroups A, B, D and E. The production 
of hyaluronidase and chondroitinase by serotype B:2 associated with HS 
is well documented (Carter and Chengappa, 1980). Hyaluronidases are 
enzymes that are normally associated with invasive mechanisms in 
bacteria, helminths and snake venoms. Type B strains, bearing other 
somatic antigens, such as the B: 3, 4 cattle and deer strains, fail to 
produce hyaluronidase. Whilst it may be concluded that hyaluronidase 
production is a character exclusively restricted to serotype B: 2 strains 
that cause HS. De Alwis et al. (1995) described a type B:2 mutant that 
was of low virulence to mice and rabbits and a virulent to cattle and 
buffaloes, yet produced hyaluronidase. No clear relationship has been 
established between the ability to produce hyaluronidase or any other 
enzyme and virulence. 
 
1.8.3 Toxins 
Serogroups A and D have been found to produce protein toxins, more 
toxigenic strains being present in serogroup D. These toxins are directly 
involved in the pathogenesis of disease, as in naturally occurring 
atrophic rhinitis in swine. No correlation has been found between toxin 
production and somatic types. Toxins of serogroups A and D are similar, 
if not identical, and antiserum produced against one neutralizes the other 
(Rimier and Rhoades, 1989). True exotoxins are not produced by strains 
 of the B group associated with HS. Toxic effect (endotoxic shock) can be 
produced by injection of culture supernatants (which contain free 
endotoxins) or endotoxin preparations. With the exception of a few 
serogroups A and D strains that produce protein toxins, proteins of P 
multocida are nontoxic. 
 
1.8.4 Bacteriocins 
 Bacteriocins are bacteriocidal proteins produced by many species of 
bacteria and which are active against members of their own species or 
closely related species. Production of bacteriocins is believed to be 
determined by a genetic element. Bacteriocins activity has been 
demonstrated in bovine and avian strains of P. multocida (Rimier and 
Rhoades, 1989). Thirty-three bovine and bison strains belonging to 
serotypes A, B and D were tested for bacteriocins activity Chengappa 
and Carter, (1977); 14 were found to produce bacteriocins. Seventeen 
strains were susceptible to their bacteriocins. The role of bacteriocins in 
the pathogenesis of disease has not been investigated. 
 
1.9 Immunity to Pasteurella multocida 
 A protective immune response comprises humoral immunity or cellular 
immunity, or both, is effective to eliminate or reduce the load of 
organism. Humoral immunity or antibody mediated immunity is a main 
type of immunity against P.multocida specially that LPS of P.multocida 
stimulates antibody production (Wijewardana and Sutherland, 1990). 
 
Proteins are believed to be important immunogens and play a vital role 
in the protective mechanism. The association of outer membrane 
proteins (OMPs) with protective immunity has been widely investigated. 
 Muniandy and Mukkur, (1993) observed that the immunogenicity of 
certain LPS preparations was due to the presence of OMPs.  
 
Serological relationships exist between LPS of serogroups B and E 
(Mosier, 1993). Electrophoretic analysis of purified LPS preparations 
has also established relationships between B and E and some type A 
strains (Rimier, 1990). This is not surprising, since all strains of both 
Asian and African origin possess the Namioka somatic antigen type 6 
and Heddleston type 2, although in the two serotyping procedures the 
LPS components used are different (De Alwis, 1987). Although crude 
LPS preparations are associated with immunity, it has been shown that 
highly purified LPS are nonimmunogenic to mice and rabbits (Muniandy 
et al., 1993). 
The OMPs of gram-negative bacteria such as porin and OmpA have been 
considered effective vaccine candidates. Two major OMPs of 
P.multocida  are related to the families of porin (protein H; OmpH) and 
heat modifiable (OmpA). Based on the electrophoretic migration of 
OmpH, different OMP patterns were identified among capsular serotype 
strains of P. multocida, representing various host species and geographic 
origins, while the electrophoretic mobility of OmpA of P. multocida 
varied slightly among different strains OmpH  possessed both specific 
and cross-reacting epitopes which are abundantly expressed on the 
bacterial surface. OmpA possessed cross-reacting epitopes which are not 
exposed on the cell surface, as shown by immunoelectron microscopy 
cited by Vasfi and Mittal, (1997). 
1.10 common antigens 
P. multocida shares common antigens with other closely related gram-
negative bacteria. Antigenic relationships with Yersinia 
 paratuberculosis, Mannheimia haemolytica, Haemophilus canis, 
Haemophilus influenza, Actinobacillus lignieresi and Escherichia coli 
have been reported (Bain, 1963; Prince and Smith, 1966). Cross-
protection has been detected in a study of 11 isolates of P. multocida 
from cases of HS, bovine pneumonia and fowl cholera were showed to 
belong various serotypes (Rimier, 1996). A serotype A:5 strain and a 
fowl cholera strain were found to protect against a number of other 
strains, irrespective of the disease caused. This protection was attributed 
to antigen components of molecular weight 20-120 kDa. 
 
Homogeneity in protein profiles among 14 strains associated with HS 
was detected. Strains of Asian and North American origin (B:2) 
displayed a major protein band of molecular mass 32 kDa. On other 
hand, strains of African origin (E:2), gave a similar band at 37 kDa. 
Other bands at 27, 45 and 47 kDa were shared by all strains, irrespective 
of serotype. Using monoclonal antibodies and an immunoblotting 
technique Ramdani and Adler, (1993) identified protein fractions of 29 
and 36 kDa in the cytoplasmic and periplasmic fractions and 42 kDa in 
the membrane fraction. 
 
1.11 Diagnosis 
A clinical, provisional diagnosis of HS is based on a combination of clinical 
signs, gross pathological lesions and a consideration of relevant epidemiolo-
gical parameters and other similar diseases prevalent in the locality. A 
variety of diagnostic techniques have been developed over the years for HS. 
These include Blood smear, culture and biological tests for isolation of the 
causative agent as using biochemical, serological tests and molecular 
methods such as PCR, (Benkirane and De Alwis, 2002). 
 1.11.1 Clinical Signs: 
The majority of cases in cattle and buffalo are acute or peracute with 
death occurring from 6 to 24 hours after the first recognized signs. In a 
few outbreaks, animals may survive for as long as 72 hours. Dullness, 
reluctance to move, and elevated temperature are the first signs. 
Following these signs, salivation and nasal discharge appear, and 
edematous swellings are seen in the pharyngeal region and then spread to 
the ventral cervical region and brisket. Visible mucous membranes are 
congested, and respiratory distress is soon followed by collapse and 
death. Recovery, particularly in buffaloes, is rare. Chronic 
manifestations of hemorrhagic septicemia do not appear to occur (De 
Alwis, 1992). 
 
1.11.2 Gross Lesions 
Widely distributed hemorrhages, edema, and general hyperemia are the 
most obvious tissue changes observed in infected animals. In almost all 
cases, there is an edematous swelling of the head, neck, and brisket 
region. Incision of the edematous swellings reveals a coagulated 
serofibrinous mass with straw colored or blood-stained fluid. This edema 
distends tissue spaces. There are subserosal petechial hemorrhages 
throughout the animal, and blood-tinged fluid is frequently found in the 
thoracic and abdominal cavities. Petechiae may be found scattered 
throughout some tissues and lymph nodes, particularly the pharyngeal 
and cervical nodes, which are also swollen and often hemorrhagic (OIE 
Manual, 2008). 
 
 
 
 
 1.11.3Collection of rewarding specimen 
The septicaemia in HS occurs at the terminal stage of the disease. 
Therefore, blood samples taken from sick animals before death may not 
always contain P. multocida organisms. A blood sample or swab 
collected from the heart is satisfactory if it is taken within a few hours of 
death. . If there is no facility for postmortem examination, blood can be 
collected from the jugular vein by incision or aspiration (Wijewardana et 
al., 1986). 
 
1.11.4 Morphology and staining 
This organism is short rod or coccobacillus, 0.2-0.4 by 0.6-2.5 mm in 
size. Repeated laboratory subcultures of old cultures or cultures have 
grown under unfavorable conditions tend to be pleomorphic and longer 
rods and filamentous forms appear. In tissues exudates and recently 
isolated cultures, the organism shows the typical coccobacillary forms. It 
is a gram-negative organism and in fresh cultures and animal tissues, 
gives typical bipolar staining, particularly with Leishman or methylene 
blue stain (Wijewardana et al., 1986). 
 
1.11.5 Growth characteristics and colony morphology 
P. multocida grows in most common laboratory media such as nutrient 
agar but the growth is very poor. Special media such as dextrose-starch 
agar and casein-sucrose-yeast (CSY) medium support an abundant 
growth. Blood agar and CSY agar with 5% blood (bovine, sheep) are 
convenient media for routine laboratory culture (Wijewardana, et al 
1986). The optimum growth temperature is 35-37°C. In enriched media 
at 37°C; colonies 1-3 mm in diameter are produced after 18-24 hours 
culture. The organism shows different types of colonies, which are 
 related to the capsular type. Colonies of types B and E vary in size, 
depending on the degree of capsulation. They will range from larger 
greyish colonies, when freshly isolated or when grown in media 
containing blood serum, to smaller colonies that give a yellowish-green 
or bluish green iridescence when viewed in transmitted light. Rough 
colonies may be produced by old cultures. These are the smallest 
colonies of all forms, and are noniridescent in oblique light. Production 
of rough colonies is the result of loss of capsular material or loss of LPS. 
Passage of rough cultures in natural host animals or laboratory animals 
or subculture in media containing animal tissues, causes reversion to the 
capsulated, iridescent colony forms. Dissociation also occurs during 
storage of stock cultures either in stock culture media or in lyophilised 
form. In such instances, an animal passage should be carried out upon 
reconstitution of the stock culture (Wijewardana et al., 1986). 
 
1.11.6 Biochemical properties 
Many biochemical methods have been used to study P. multocida. These 
include: catalase, indole, oxidase and sugars fermentation tests. Shigidi 
and Mustafa, (1979) tested 42 strains of P.multocida isolated from 
different outbreaks of HS and from healthy cattle in various parts of 
Sudan. The isolates did not cause haemolysis on blood agar (BA) and 
failed to grow on MacConkey agar (MCA). All strains produced indole, 
catalase, oxidase and reduced nitrate to nitrite. All the strains fermented 
xylose, glucose, fructose, galactose, mannose, sucrose and sorbitol with 
acid production. None of the strains fermented rhamnose, lactose, 
trehalose, raffinose, dulcitol or salicin. The results were variable with 
some of the carbohydrates; 16 strains fermented arabinose, four 
fermented maltose and nine fermented mannitol. None of the strains 
 changed litmus milk, utilized citrate, liquefied nutrient gelatin or 
produced urease. 
 
1.11.7 Serological test and serotyping methods 
Serological tests for detecting antibodies are not normally used for 
diagnosis. The indirect haemagglutination test (IHA) can be used for this 
purpose. High titers detected by the IHA test are indicative of recent 
exposure to HS. As HS is a disease that occurs mainly in animals reared 
under unsophisticated husbandry conditions, where disease-reporting 
systems are also poor, there is often considerable delay in notification of 
outbreaks. When notification is made in such situations, high IHA titers 
from 1/160 up to 1/1280 or higher among in-contact animals surviving in 
affected herds, are indicative of recent exposure to HS (OIE Manual, 
2008). 
 
Several serotyping tests are used for the identification of the HS-causing 
serotypes of P. multocida. These consist of rapid slide agglutination 
(Namioka & Murata, 1961 a) indirect haemagglutination (IHA) test for 
capsular typing (Carter, 1955) and an agglutination test using 
hydrochloric-acid-treated cells for somatic typing (Namioka and Murata, 
1961b). The agar gel immunodiffusion (AGID) test (Heddleston et al, 
1972; Wijewardena, 1982; Anon, 1981) and the counter immune 
electrophoresis test (CIEP) are also used for this purpose (Carter and 
Chengappa, 1981) 
 
 
 
 
      1.11.8 Molecular methods 
Molecular methods such as PCR, ribotyping or restriction 
endonuclease analysis have an epidemiological significance because 
they enable strain differentiation within serotypes and hence some 
epidemiological inferences, for investigations extending beyond 
routine diagnosis. (Benkirane & De Alwis, 2002).  
 
1.11.8.1 Polymerase chain reaction technique 
The polymerase chain reaction (PCR) is a technique developed in 1984 
by Kary Mullis, (Mullis, 1990). widely used in molecular biology, 
microbiology, genetics, diagnostics, clinical laboratories, forensic 
science, environmental science, hereditary studies, paternity testing, 
and many other applications. The name, polymerase chain reaction, 
comes from the DNA polymerase used to amplify a piece of DNA by 
in vitro enzymatic replication. The original molecule or molecules of 
DNA are replicated by the DNA polymerase enzyme, thus doubling 
the number of DNA molecules. Then each of these molecules is 
replicated in a second "cycle" of replication, resulting in four times the 
number of the original molecules. Again, each of these molecules is 
replicated in a third cycle of replication. This process is known as a 
"chain reaction" in which the original DNA template is exponentially 
amplified. With PCR it is possible to amplify a single piece of DNA, 
or a very small number of pieces of DNA, over many cycles, 
generating millions of copies of the original DNA molecule. PCR has 
been extensively modified to perform a wide array of genetic 
manipulations, diagnostic tests, and for many other uses (Saiki et al., 
1985; Saiki et al., 1988). 
 
 PCR technology can be applied for rapid, sensitive and specific detection 
of P. multocida. The rapidity and high specificity of two of the P. 
multocida-specific assays provide optimal efficiency without the need 
for additional hybridization. Although the use of hybridization can 
confirm specificity, this approach is usually possible only in specialized 
laboratories. The P. multocida-specific PCR identify all subspecies of P. 
multocida (OIE, 2008). 
Nucleic acid based differentiation of closely related P.multocida vaccinal 
strains was performed after morphological and biochemical 
characterization. HS-specific and species-specific PCR analysis of P. 
multocida vaccinal strains was demonstrated to be useful in 
distinguishing hemorrhagic septicemia-causing type B strains. The PCR 
assay performed for species specific P. multocida by using primer pair 
KMT1T7 and KMTISP6 resulted in amplification of all the strains. 
Another PCR analysis carried out for HS causing strain conformation by 
using primer pairs KTT72 and KTSP61 showed that only H.S. causing 
strains were amplified. It was also observed that PCR amplification 
performed directly on bacterial colonies or cultures was an extremely 
rapid, sensitive method of P. multocida identification (Townsend et al., 
1998). 
Recently a multiplex PCR was introduced as a rapid alternative to 
capsular serotyping system. Comparative analysis of the five capsular 
biosynthetic regions confirmed a genetic basis for the serological 
differences observed between strains. By using these genetic differences, 
a rational, DNA-based typing system for P. multocida was developed 
(Townsend et al., 2001). Notably, the PCR-based system was not 
affected by the geographical distribution of isolates. For example, 
 isolates classified as serogroup A by conventional serotyping from 
Australia, Vietnam, and the United States have all produced the 
appropriate amplicon with the serogroup A cap-specific primers. 
However by this technique only the capsular serotyping information 
could be ascertained (Townsend et al., 2001). Gautam et al., (2004) 
introduced a PCR technique specific for P.multocida serogroup A.  
1.11.8.2 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SDS-PAGE 
SDS PAGE is a technique used in biochemistry, genetics and molecular 
biology to separate proteins according to their electrophoretic mobility;  
a function of  the length of polypeptide chain or molecular weight as 
well as degree of protein folding, posttranslational modifications and 
other factors. The solution of proteins to be analyzed is first mixed with 
sodium dodecyl sulphate  (SDS), an anionic detergent which denatures 
secondary and non–disulfide–linked tertiary structures, and applies a 
negative charge to each protein in proportion to its mass. Without SDS, 
different proteins with similar molecular weights would migrate 
differently due to differences in folding, as differences in folding 
patterns would cause some proteins to better fit through the gel matrix 
than others. Adding SDS solves this problem, as it linearizes the proteins 
so that they may be separated strictly by molecular weight primary 
structure, or number and size of amino acids. The SDS binds to the 
protein in a ratio of approximately 1.4 g SDS per 1.0 g protein although 
binding ratios can vary from 1.1-2.2 g SDS/g protein, giving an 
approximately uniform mass: charge ratio for most proteins, so that the 
distance of migration through the gel can be assumed to be directly 
related to only the size of the protein. A tracking dye may be added to 
 the protein solution to allow the experimenter to track the progress of the 
protein solution through the gel during the electrophoretic run (Laemmli, 
1970).  
 
The protein analysis of P. multocida organism is usually performed by 
(SDS-PAGE) technique. It is important that strains of P. multocida used 
for the production of vaccine be antigenically similar and 
immunologically homologous to the strains of organisms prevalent in the 
field (Sridevi et al., 1999). 
1.11.8.2.1 SDS PAGE of whole cell lysate  
Johnson  et al. (1991) examined a wide range of P. multocida strains of 
different serogroups by electrophoretic techniques. They found a high 
degree of homogeneity in protein profiles among 14 strains associated 
with HS. Strains of Asian and North American origin (B:2) displayed a 
major protein band of molecular mass 32 kDa like strains of African 
origin (E:2). Further, it also gave a similar band at 37 kDa. Other bands 
at 27, 45 and 47 kDa were shared by all strains, irrespective of their 
serotype. 
  
HS related P. multocida isolates, collected from different localities of 
Pakistan, were characterized on the basis of whole cell proteins by (SDS-
PAGE) technique. He found no quantitative difference was observed 
among different isolates (Nawaz, 2006). 
 
1.11.8.2.2 SDS PAGE of Outer Membrane Protein (OMPs)  
 The analysis of total membrane proteins by (SDS-PAGE), in cells of 
serotype B:2 strains grown under iron-replete and iron-restricted 
conditions (Veken et al. 1994;Veken et al. 1996), revealed different 
 specific protein components that were expressed by the same strain, 
depending on the culture conditions . A variety of protein components of 
various molecular weights have also been isolated from the Indian 
vaccine strain P52, by various extraction methods including sonication 
and precipitation with ammonium sulfate gel. Their immunogenic merits 
have been tested in rabbits and mice (Pati et al. 1996; Srivastava, 1996). 
 
P.multocida strains isolated from adult cattle with HS and calves with 
typical bronchopneumonia, to determine electrophoretic profiles of 
OMPs and compare reference strains of the serotypes B:2 and A:3, using 
SDS-PAGE. The electrophoretic profiles of field isolates of P. multocida 
sampled from adult cattle and calves, and the reference strains, serotypes 
B:2 and A:3, exhibited 9 to 14 bands with different molecular weights, 
ranging from 18 kDa to 115 kDa (Jablonska & Opacka, 2006). 
 
1.11.8.3 Western Blotting 
The Western blot, i.e. protein immunoblot is an analytical technique used to 
detect specific proteins in a given sample of microbial homogenate or 
extract. It uses gel electrophoresis to separate native or denatured proteins by 
the length of the polypeptide (denaturing conditions) or by the 3-D structure 
of the protein (native/ non-denaturing conditions). The proteins are then 
transferred from the gel to nitrocellulose membrane, where they are probed 
detected using antibodies specific to the target protein (Towbin et al. 1979; 
Renart et al. 1979). This method is used in the fields of molecular biology, 
biochemistry, immunogenetics and other molecular biology disciplines. 
The method originated from the laboratory of George Stark at Stanford. The 
name western blot was given to the technique by W. Neal (Burnette, 1981) 
and is a play on the name Southern blot, a technique for DNA detection 
 developed earlier by Edwin M. Southern. Detection of RNA is termed 
northern blotting and the detection of post-translational modification of 
protein is termed Eastern blotting. 
1.11.8.3Transfer method 
Transfer can be done in wet or semi-dry conditions. Semi-dry transfer is 
generally faster but wet transfer is a less prone to failure due to drying of the 
membrane and is especially recommended for large proteins, >100 kda 
(Hames and Rickwood, 1998). 
1.11.8.3.1Wet transfer  
 The gel and membrane are sandwiched between sponge and paper 
(sponge/paper/gel/membrane/paper/sponge) and all are clamped tightly 
together ensuring no air bubbles have formed between the gel and 
membrane. The sandwich is submerged in transfer buffer to which an 
electrical field is applied. The negatively charged proteins travel towards the 
positively-charged electrode, but the membrane stops them, binds them, and 
prevents them from continuing on.  A standard buffer for wet transfer is the 
same as the 1X Tris-glycine buffer used for the migration/running buffer 
without SDS but with the addition of methanol to a final concentration of 
20%. For proteins larger than 80 kDa, it is recommended that SDS is 
included at a final concentration of 0.1%. 
 
 1.11.8.3.2 Semi-dry transfer 
  A sandwich of paper/gel/membrane/paper wetted in transfer buffer is 
placed directly between positive and negative electrodes (cathode and 
anode respectively). As for wet transfer, it is important that the 
membrane is closest to the positive electrode and the gel closest to the 
negative electrode. The proportion of Tris and glycine in the transfer 
 buffer is not necessarily the same as for wet transfer (Hames and 
Rickwood, 1998). 
 
1.11.8.4Characterization of P. multocida antigen by immunoblotting 
Immunoblotting was done for serotype B:2. As a step for identification 
of individual antigens that may protect against HS, proteins present in a 
sonicated cell extract (SCE) and outer-membrane protein (OMP) 
preparation of a wild-type P. multocida serotype B:2 were investigated 
by immunoblotting with sera from calves that had been protected against 
challenge with a virulent strain of P. multocida B:2 by vaccination with a 
aroA derivative live-attenuated strain B. Five proteins in SCE, of 
approximately 50, 37,30, 26 and 16 kDa, were recognised by the sera. In 
an OMP preparation, two bands, at 37 and 50 kDa, were recognised as 
strongly immunogenic (Ataei et al., 2009). Using monoclonal antibodies 
and an immunoblotting technique Ramdani & Adler, (1993) identified 
protein fractions of 29 and 36 kDa in the cytoplasmic and periplasmic 
fractions and 42 kDa in the membrane fraction.  
 
Western blot was used to confirm that immunogens of P. multocida in 
rabbits, compared with the radioimmunoprecipitation procedure (RIP) 
for identification of outer membrane immunogens and also for 
identification of antibody-accessible proteins on the cell surface is 
important in the selection of vaccine candidates, indicating that the two 
systems were similar in detecting P. multocida outer membrane 
immunogens (Lu et al., 1988). 
 
Immunoblotting and ELISA was used to evaluate antigenic complexes 
immunogenic properties of outer membrane proteins (OMPs) and iron-
 regulated outer membrane proteins (IROMPs) prepared from strain of 
serotype B:2,5 for the immunization of calves. The occurrence of 
antibodies against specific outer membrane proteins as detected by 
immunoblotting and ELISA in the sera of immunized cattle suggest a 
beneficial immunogenicity of the vaccines (Kedrak & Opacka, 2003). 
 
1.12 Prevention and control 
In endemic areas the only practical ways to protect animals are by an 
organized program of vaccination and maintenance of animals in as good 
a condition as possible. Avoiding crowding, especially during wet 
conditions will also reduce the incidence of disease. Animals that are 
exposed to P. multocida serotypes 6:B and 6:E and survived are 
considered solidly immune (OIE Mannual, 2008). 
1.12.1Vaccination 
Peracute nature of disease, febrile condition of animals and development 
of resistance against antibiotics usually result in therapeutic failure. 
Therefore, an effective control of disease could only be achieved by 
vaccination. The three types of vaccines used against HS are bacterins, 
alum-precipitated vaccine (APV) and oil-adjuvanted vaccine (OAV). To 
provide sufficient immunity with bacterins, repeated vaccination is 
required. Administration of dense bacterins can give rise to shock 
reactions, which are less frequent with the APV and almost nonexistent 
with the OAV. 
 
 
 1.12.1.1 Inactivated vaccines 
Vaccination is routinely practiced in endemic areas where three 
preparations are used; dense bacterins combined with either alum 
adjuvant or oil adjuvant, and formalin-inactivated bacterins injected 
subcutaneously (s.c.). There preparations give some protection against 
HS, but they provide only short-term immunity (Chandrasekaran et al., 
1994). The high viscosity of oil-adjuvant vaccines makes them 
unpopular among field users. The oil adjuvant bacterin is thought to 
provide protection for up to one year and the alum bacterin for 4–6 
months. Non- the –less, there is a disadvantage, that maternal antibody 
interferes with vaccine efficacy in calves (Shah and De Graaf, 1997; 
Verma and Jaiswal, 1997, 1998; Sawada et al, 1985) 
 
1.12.1.2 Live attenuated vaccines 
A live HS vaccine prepared using an avirulent P. multocida strain B:3,4 
deer strain has been used for control of the disease in cattle and 
buffaloes over 6 months of age. It is administered by intranasal aerosol 
application; a natural route of entry into the host. This allows targeting 
the immunostimulatory factors at the same sites of the immune system 
that occur in the natural infection. For live strains to be used as 
vaccines, the mode of attenuation should be well defined. The vaccine 
has been recommended by the Food and Agriculture Organization of 
the United Nations (FAO) as a safe and potent vaccine for use in Asian 
countries.  However, there is no report of its use in other countries and 
killed vaccines are the only preparations in use by the countries affected 
with HS (OIE, 2008; Myint et al. 2005; Myint and Carter, 1989). 
 
 
 CHAPTER TWO 
MATERIAL AND METHOD 
2.1 Pasteurella multocida 
Lyophilized vaccine strains B and E were obtained from Biological 
Department of the Central Veterinary Research Laboratories (CVRL), 
Soba, Sudan. Lyophilized field strains B and E were obtained from the 
Department of Microbiology, Faculty of Veterinary Medicine, University 
of Khartoum.  
2.2 Laboratory animals 
2.2.1 Rabbits:  
Four healthy local breed of rabbits were purchased from the market. The 
animals were kept under close observation and were fed well for ten 
days. 
2.2.2 Rats: 
Two healthy Rats were obtained from the Department of Microbiology 
Faculty of Veterinary Medicine. 
2.3 Glass wares: 
Petri dishes, flasks, beakers, bottles and sonicator tubes were sterilized 
by oven at 160 °c for 2 hours. 
2.4 Plastic wares: 
Eppendorf tubes, plain tube and rubbers were sterilized by autoclave at 
121°c for 15 min. 
2.5 Pasteurella multocida strains: 
Each of the lyophilized B and E P. multocida vaccine was reconstituted 
in nutrient broth (Appendix, І) and was incubated at 37°c for 24 hours. 
 Point five milliliter of each strain culture was revived in a rat by giving 
subcutaneous injection. The rats died in less than 24 hours and were 
dissected aseptically. Heart blood, heart and liver were collected and 
inoculated into blood agar (Appendix, І) and incubated at 37°C for 24 
hours. The growth was observed and colonial morphology was checked. 
Blood smears stained with methylene blue were prepared to check the 
bipolarity (Carter, 1985). 
2.6 Hyperimmune serum production 
Hyperimmune serum was prepared against specific strains in rabbits. 
Vaccine strains B and E were cultured in brain heart infusin broth (BHI) 
(Appendix, І) for 24 hours in shaking water bath. About fifty ml of 
culture for each strain were centrifuged at 4000 rpm at 4°C for 15 min 
(Megafuge, Germany). The pellet was washed 3 times with phosphate 
buffer saline (PBS) pH 7.2 (Appendix, П), and the final pellets were 
suspended in 5 ml of 0.3% formalin saline and were left overnight to kill 
the bacteria .The suspensions were  centrifuged at 4000 rpm at 4°C for 
15 min and the pellets were suspended in 10 ml normal saline. The 
turbidity of the cell suspension was adjusted to that of McFarland's tube 
No. 3 which corresponds to108 cfu/ml. 
2.6.1 Immunization schedule 
Rabbits were inoculated intravenously in ear vein at 3 day intervals with 
0.2, 0.5, 1.0, 1.5 and 2.0 ml of the killed bacteria suspension. Proof 
bleeding was done and the sera were detected for presence of antibody 
by Agar gel immunodiffusion test. The rabbits were inoculated 
subcutaneously 1 week after the last injection with 0.5 ml of a similar 
suspension as a booster dose to raise antibody titer. The animals were 
 bled 10 days later. The serum was separated and stored at –20°C as 
described by OIE Manual, (2008). 
2.6.2 Detection of antibody 
Agar gel immunodiffusion (AGID) test was done to detect the presence 
of antibodies in serum. 
2.6.2.1 Agar gel immunodiffusion test 
The gel was prepared by dissolving 1gram of agarose (SIGMA) powder 
was dissolved in 100 ml of 0.1M PBS (Appendix, П) and was melted in 
microwave. A volume of 0.5ml of phenol was added as bacteriostatic 
agent. The agar solution was poured in 60 mm petri dishes and left to 
cool and solidify. Wells were cut with gel puncture. Thirty micro litter of 
whole cell lysate (WCL) bacterial antigen was placed in one well and in 
other well 30µl of the serum was dropped. The gel incubated in humidity 
chamber for 24-48 hours. The test was read against the illuminator 
chamber.   
2.7 Whole cell lysate preparation 
Each P. multocida vaccine strain was cultured in 250 ml BHI broth and 
incubated at 37°C overnight in shaking water bath. Purity of each culture 
was checked. The cultures were centrifuged at 4000 rpm for 15 minutes 
at 4°C in 15 ml falcon tubes and pellets were collected and washed 3X 
with PBS. The final pellets were redissolved in distilled water vortexed 
and sonicated in sonicator (MSE-England) for 30 seconds stroke and 30 
seconds cooling upto10 cycles, the amplitude was kept 18 rpm in cycles 
(Srivastava, 1998). Cell debris and unbroken cells were removed by 
centrifugation at 3000 rpm for 15 min and the supernatants were kept at -
20°c until used. 
 2.7.1 SDS PAGE 
The SDS PAGE of whole cell lysate (WCL) vaccine strains were carried 
out according to Lammeli method (Lammeli, 1979) using electrophoresis 
apparatus (Bio Rad, Germany) with 12% separating gel and 5% stacking.  
Polyacrylamide gel was prepared and polymerized by the addition of 
tetramethylenediamine (TEMED) (Sigma). 
2.7.1.1 Preparation of glass plates  
Firstly, the glasses were cleaned up with alcohol and the bottom of the 
electrophoresis glasses were sealed with 2% agarose and were left to 
solidify. 
2.7.1.2 Separating gel 
The seperating gel containing 4.2 ml of 30% acrylamide+bisacrylamide, 
in 1.5 M Tris-HCl,100 µl of 10 %SDS,  3.2 ml D.W and 100 µl 99% 
ammonium persulphate (APS) (Sigma). Fourteen microliter of TEMED 
were added immediately before pouring the separating gel and leveled 
by methanol. Methanol was discarded and distilled water was added and 
the glass plates were covered with wet tissue and kept for overnight at 
4°C for better resolution. 
2.7.1.3 Stacking gel 
The stacking gel was prepared by adding 1.3 ml of 30% 
acrylamide+bisacrylamide, in 0.5M Tris-HCl, 100 µl of 10 %SDS, 2 ml 
D.W and 100 µl of APS. Ten microliter of TEMED was added and 
immediately poured off the stacking gel and the comb was placed, the 
gel was left to solidify, then the comb was removed. 
 
 
 2.7.1.4 Sample loading  
Ten microliter of sample were mixed with 10 µl of sample buffer 
(Appendex, III) containing bromophenol blue and boiled for 5 min. Then 
10 µl of heated sample was loaded into each well and also 5 µl of protein 
marker 10-175kDa (gene direx, USA) was loaded along with the sample. 
The electrophoresis apparatus was filled with running buffer (Appendix, 
III). Then the apparatus was connected with constant voltage (100v) for 
2hours or until the bromophenol blue reached the bottom of the slides. 
2.7.1.5 Staining and destaining of gel 
The gels were placed into container with a staining solution (Appendix, 
III) containing Coomassie brilliant blue dissolved in methanol. Gels 
were left in staining solution for overnight under slow shaking. The gels 
were destained in destaining solution (Appendix, III) containing 
methanol until the bands become visible. 
2.7.2 Western blotting 
2.7.2.1 Enzyme antibody conjugate: 
The conjugate antibody was antiwhole IgG molecule, goat anti rabbit 
IgG conjugated with horse radish peroxidase enzyme purchased from 
Adcam Company, Malaysia 
2.7.2.2 Protein transferring 
Proteins were electrophoretically transferred to nitrocellulose membrane 
of average pore size 0.45 Mm (Schleicher and Schueul, Gerrmany). The 
sponge pads were wetted with transfer buffer and were put in the transfer 
apparatus, place one piece of wet filter paper, the nitrocellulose 
membrane, the gel, another piece of wet filter paper were placed in 
respective order. Bubbles were squeezed out by adding transfer buffer 
 (Appendix, IV) at every step and by rolling with a pipette after each 
addition. The apparatus was filled with transfer buffer and the lid was 
closed and was connected to the power supply and run at 100 volts for 1 
hour. 
2.7.2.3 Immuno peroxidase staining of nitrocellulose membrane 
The nitrocellulose membranes were put on a container and were covered 
with 2% gelatin as blocking buffer (Appendix, IV). Then the membranes 
were incubated on the shaker with low speed at room temperature for 1 
hour. The blocking buffer was discarded and the membranes were 
covered with primary antibody diluted at 1:200 in serum diluent 
(Appendix, IV) and incubated on a shaker at room temperature for 1 
hour. The membranes were washed with washing buffer (Appendix, IV) 
three times (5 minutes for each wash at high speed). Then the 
membranes were covered with secondary antibody (antirabbit horse, 
raddish peroxidase- conjugated) (Appendix, IV) diluted 1:1000 and 
incubated for 2hours. This was followed by washing the membranes 
three times like in the first wash. Finally the substrate 4-chloro α naphtol 
(Appendix, IV) was added and incubated for 15 min. Distilled water was 
added to stop the reaction. The membranes were air dried and preserved 
in dark until photographed (Towbin, 1979).  
2.8 PCR method 
2.8.1 PCR Primers 
Primers for each strain were obtained as freeze dried oligonucleotide 
(Vivantis, Malaysia) with sequences that amplify capsule gene with 
specific molecular weight (MW) band according to strain. 
Strain B 
 CAPB-FWD 5’-CAT-TTA-TCC-AAG-CTC-CAC-C-3’ MW 5668 
CAPB-REV 5’-GCC-CGA-GAG-TTT-CAA-TCC-3’ MW 5460 
Strain E 
CAPE-FWD 5’TCC-GCA-GAA-AAT-TAT-TGA-CTC-3’ MW 6389 
CAPE-REV 5’-GCT-TGC-TGC-TTG-ATT-TTG-TC-3’ MW 6096 
2.8.2 DNA extraction  
Two methods of DNA extraction were used. The first method of DNA 
extraction was by boiling method and the second method by the kit 
(PUREGENE ,Gentra System, Minneapolis, USA). 
2.8.2.1 Boiling extraction 
A pure colony of P. multocida was inoculated into 5 ml of BHI broth and 
incubated at 37°C for 24 h. One point five milliliters of this broth culture 
was transferred into an eppendorf tube and centrifuged at 3000 x g for 10 
min. The pellet was washed twice in PBS and the final pellet was 
resuspended in 100 µl of sterile deionized distilled water. The mixture 
was boiled for 30 min and immediately chilled on ice for 30 min. The 
sample was then thawed and centrifuged at 3000 x g for 5 min. The 
supernatant was stored at -20°C for further use as DNA template as 
described by Antony et al. ( 2007). 
2.8.2.2 Kit extraction: 
DNA was extracted by using DNA isolation kit. Five hundred microlittre 
of overnight bacterial BHI culture were centrifuged at 15.000xg in 1.5ml 
micro tube for 5 second to pellet cells and carefully the supernatant were 
removed. Then 300µl of cell lysis solution was added to the cells pellet, 
 and the mixture was inspirated and expirated by micropipette until cells 
were suspended and incubated at 80°C for 5 min, followed by the 
addition of 1.5µl RNase a solution to the cell lysate. The samples were 
then mixed by inverting the tube 25 times and the tubes were incubated 
at 37°C for 15 minutes, cooled to room temperature and 100µl protein 
precipitation solution was added to the cell lysate. The tubes were 
vortexed at high speed for 20 seconds and then centrifuged at 15.000xg 
for 3 minutes. Then 300µl of 100% Isopropanol were added to the 
supernatant fluid into a clean 1.5 microfuge tube, mixed by inverting 
gently 50 times, and centrifuging at 15.000xg for 1 minute to pellet the 
DNA. The supernatant was poured off and the tubes were drained 
briefly, after that DNA was washed with 300µl of 75% ethanol, 
centrifuged at15.000xg for 1 minute and the ethanol was poured off. The 
tubes were then allowed to dry for 10 minutes. 20µl DNA hydration 
solution was added and DNA was dissolved by incubating for 1 hour at 
65°C and then stored at -20°C until used. 
2.8.3 DNA amplification: 
DNA amplification was done in PCR tube, 50 µl reaction mixture was 
prepared. One microlitres of template DNA was added to a reaction 
mixture containing 3.2 µM each of primer, 200 µM of each dNTP, 1 X 
Taq buffer with 1.5 M MgCl2 and 2 units of Taq DNA polymerase. The 
amplification reaction was carried out in an automated thermal cycler 
(Biometra, Germany) according to the following programme, an initial 
denaturation at 94°C for 5 min, followed by 30 cycles of denaturation at 
94°C for 30 second, annealing at 56°C for 30 second, extension at 72°C 
for 30 second and a final extension at 72°C for 5 min. 
 
 2.8.3.1 PCR product detection: 
Detection was done by electrophoresis to determine molecular weight of 
bands. 
2.8.3.2 Electrophoresis of PCR product  
     The product was analyzed by 2% agarose gel with 0.05% ethidium 
bromide in 1x tris boric EDTA (TBE) running buffer (Appendix, V) 
prepared by adding 2g agarose to100 ml of TBE buffer and melted in 
microwave then 1.5 µl of ethidium bromide were added and poured in 
electrophoresis apparatus, the comb was placed until solidification of 
gel. Then comb was removed and samples were loaded. Three 
microlittre PCR product was mixed with 3µl loading dye (Appendix, V) 
and was loaded into gel wells. Standard molecular size marker low range 
DNA ruler with fragments size 100 bp was also loaded and used as DNA 
molecular size marker to ascertain the size of the amplified PCR product.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 CHAPTER THREE 
RESULT 
 
3.1 Growth characteristic 
P. multocida, namely B:6 and E: 6 vaccine strains were showed luxuriant 
growth on blood agar having translucent grayish colonies varies in size 
and there was no blood hemolysis (Fig,1). In liquid media showed 
homogenous growth. The growth was better in BHI broth than nutrient 
broth. 
3.2 Morphological characteristic 
P. multocida when stained with Gram stain showed Gram negative short 
rod or coccobacilli. Blood smears from injected rats showed bipolar 
staining bacteria (Fig,2). 
3.3Agar gel immune diffusion test  
 Sera were collected from immunized rabbits and tested for presences of 
antibody .The gel showed presence of continuous precipitation line 
between strain B and strain E against the sera of strain E or B and other 
line which might be polysaccharide (Fig,3). 
3.4 SDS PAGE 
For the analysis of proteins of P. multocida organism, SDS-PAGE was 
done according to Lammeli method (Lammeli, 1979). The gel obtained 
after analysis was stained with Coomassie brilliant blue dye. By this 
technique different polypeptides bands of the organism’s proteins were 
observed. The protein profiles of P. multocida whole cell lysate prepared 
for each strain, there were 15 protein bands of molecular weight 175 
 kDa, 165 kDa, 150 kDa,123 kDa, 102 kDa, 90 kDa, 85 kDa, 70 kDa, 64 
kDa,60 kDa, 51 kDa,42 kDa,37 kDa, 22 kDa and16 kDa (Fig,4). Some 
of these bands are major protein with molecular weight 102 kDa, 85 kda, 
70 kDa, 62 kDa, 42 kDa, and 37 kDa. Polysaccharides were observed as 
a thin a band near the start of the gel. 
3.5 Western blotting  
Immunoblotting using antiserum against P. multocida strain B prepared 
in rabbits and using nitrocellulose membrane containing bands 
transferred from gel according to Towbin (1979) method, revealed eight 
protein bands of molecular weight 175 kDa, 102 kDa, 90 kDa, 85 kDa, 
70 kDa, 42 kDa, 37 kDa, and 16 kDa (Fig,5). 
3.6 PCR 
The two methods used for extraction of DNA gave good yield for DNA, 
but the Kits method was the best in yield.  
The strains of P. multocida E and B when subjected to amplification 
using the primer pairsgave an amplification of 511 bp and 760 bp for 
strain E and strain B respectively when subjected to gel electrophoresis. 
Primers of strain E amplified vaccine strain B DNA.  Field strains B and 
E were specifically amplified. Vaccine strain E gave DNA amplification 
product (band) but vaccine strain B did not give an amplification product 
(band) when strain B primers were used as depicted in Fig. 6. 
 
 
 
 
  
 
 
 
Fig .1 Growth of P. multocida in blood agar showed grayish colonies. 
 
 
 
 
 
 
 
 
  
 
 
 
Fig. 2 Pasteurella multocida bipolar staining with methylene blue  
(Blue dots) 
 
 
 
 
 
 
 
  
 
 
 
 
 
Fig.3 AGID test, continuous precipitation line between antisera against 
B and E and strain E of  P. multocida. 
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   Fig .4Whole cell lysate proteins profile of P. multocida vaccine strains by 
SDS-PAGE 
Lane 1 protein marker, lane2-5 strain E, lane 6-10 strain B, lane 11 
protein marker. 
P= polysaccharide. 
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Fig.5 Immunogenic bands of P. multocida detected with hyper 
immune serum and developed by enzyme labeled antibody. 
M= protein marker 
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Fig.6 PCR of P. multocida strain E and B field and vaccine strains 
Lane M =protein marker, lanes 1-4 boiling extraction, lanes 5-8 kits 
extraction 
1and 6 = vaccine strain B, 2 and 5= field strain B, 3 and 7= vaccine 
strain E, 4 and 8 field strain E, 9=vaccine strain B with primer E, 10 
vaccine strain B with primer E 
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 CHAPTER FOUR 
DISSCUTION 
P. multocida is an aerobic, chemo-organotrophic organism that has 
different serotypes that cause disease in animal and poultry. Serotypes 
B and E cause hemorrhagic septicaemia in cattle and buffaloes. In all 
countries where pasteurellosis occurs vaccinations are considered as 
an effective means of controlling this disease and local isolates are 
usually used for vaccine preparation. Bacterins were used for 
immunization, in addition to precipitated alum or aluminium 
hydroxide gel vaccines and dense bacterin. Further several authors 
immunized cattle with live vaccines. In order to improve the 
immunogenicity of vaccines, the causative organism has been 
fractionated and various cell surface components have been studied 
(Carter and De Alwis, 1989; Chandrasekaran et al., 1994). 
 
 In these study cultural characteristics of two P. multocida vaccine 
strains was studied on blood agar. The optimum growth temperature 
was 37°C after 18-24 hours incubation culture gave translucent 
grayish colonies that varies in size 1 to 3 mm were seen and there was 
no blood hemolysis. In liquid media incubated in shaker there was 
homogenous growth. P.multocida is Gram negative short rod that 
gave bipolar staining from tissue and these confirmed results had been 
reported by (Shigidi and Mustafa, 1979; Arawwawela et al., 1981; 
Wijewardana et al., 1986). 
 
The techniques in molecular biology have significantly increased 
understanding of the epidemiology of Pasteurella diseases. SDS-
PAGE has shown to establish the unique properties of the bacterial 
 proteins (Johnson et al., 1991). In this study the proteins profile of P. 
multocida organism was studied by SDS-PAGE and clear proteins 
bands were obtained following staining of the gel with Coomassie 
brilliant blue dye. By this technique, different polypeptides of the 
organism’s proteins were observed. The protein profiles of P. 
multocida whole cell lysate revealed 15 bands on SDS-PAGE analysis 
some of these bands are of high molecular weight include175 kDa, 
165 kdDa, 150 kDa, 123 kDa, 102 kDa protein band. Type of the 
medium used and the method of protein extraction, as the growth on 
BHI medium enhanced the production of high molecular weight (Jain 
et al., 2005) which is substantiated by the correlate observation in this 
study. Jain et al., (2005) who observed expression of protein of 
molecular weight 102 kDa along with other major OMP bands in 
capsular type B buffalo isolates. Further they also examined four 
reference strains of serotype B: 2 to determine their protein profiles 
and compared them with field isolates. Their results revealed that 
fractions of molecular weight of 25 to 55, 75, 80, 86 and 90 kDa were 
most frequently observed among all isolates and reference strains.  
In this study bands with molecular weight 90 kDa ,85 kDa, 70 kDa, 64 
kDa,60 kDa, 51 kDa,42 kDa,37 kDa, 22 kDa and16 kDa. Some of 
these bands were found by other authors. Johnson et al. (1991) 
determined the proteins profile of the capsular serotype B and E 
strains isolated from animals with hemorrhagic septicemia and placed 
the isolates in two distinct groups on the basis of the molecular masses 
(32 to 37 kDa) of the major proteins. They reported that polypeptide 
of 37 KDa was the most immunogenic of all the isolates and this band 
was found in African strain 37 kda. This finding is in agreement with 
our present result.   
 Detected band, with hyperimmune serum using immunoblotting were 
with molecular weights 175 kDa, 102 kDa, 90 kDa, 85 kDa, 70 kDa, 
42 kDa, 37 kDa and 16 kDa correspond to those bands obtained by 
Pati et al. (1996) who reported proteins of 44, 37 and 30 kDa 
determined that they were the major immunogens when use subunit 
vaccines comprising OMPs from P. multocida serotype B:2 in 
immunizing buffalo calves. There for the present study provided 
further wider OMPs are protective and could be used in vaccines 
against haemorrhagic septicaemia. 
 
The identification and sequence analysis of the biosynthetic locus of 
the capsule of an organism can lead to a greater understanding of its 
capsular polysaccharide composition and can provide a genetic basis 
for the serological differences observed between strains. Genetic 
analysis of the serogroup B biosynthetic locus revealed only three 
gene products with similarity to proteins known to be involved in 
polysaccharide biosynthesis, while six gene products had no similarity 
to known proteins. However, the structure of the type B capsule 
remains unknown (Boyce et al., 2000). 
 
Determination of the nucleotide sequence of the serogroup E 
biosynthesis region provided little information about the capsular 
polysaccharide composition. Region 2 of serogroup E contains nine 
genes, two of which showed similarity to genes involved in 
polysaccharide biosynthesis. These two genes have homologs in the P. 
multocida B:2 cap locus, indicating that N-acetyl-D-
mannosaminuronic acid is a component of both the serogroup B and 
the serogroup E capsules; the remaining seven genes, five have 
 homologs in the B:2 cap locus but still have no known function, one 
encodes a putative glycosyltransferase, and the other is unique to 
serogroup E. In our study DNA bands were obtained by serotype E 
and B using primer E cap locus and there were no bands using primers 
strain B cap locus but there was band in field strain B. This finding 
according to Townsend et al., (2001) is indicative the bivalent vaccine 
contain only strain E.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Conclusions 
- Protein profile of P. multocida is similar in two vaccine strains. 
- Some P. multocida proteins as obtained by ultrasonicaition 
followed by SDS PAGE were reported by others.  
- The study further provided that whole cell lysate, include OMPs 
of P. multocida were immunogenic and could be used in 
subunit vaccines against haemorrhagic septicaemia. 
- Bivalent haemorrhagic septicaemia vaccine when subjected to 
PCR gave amplification product for strain E only. 
- PCR can be used for capsular serotyping of P. multocida. 
 
 
 
 
  
Recommendations 
 
- Research must be done to determine if there is a difference 
between vaccine strains and field strains in protein profile. 
- Further studies are required to confirm the immunogenicity of 
these proteins prior to use them as antigen in subunit vaccine. 
- Research should be done in subunit vaccine and how to use 
them by mucosal routes to induce local immunity. 
- Strain B of national vaccine should be recharacterized. 
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 Appendices 
Appendix І 
 
Bacteriological media: 
Nutrient Broth: 
Meat (beef) extracts                                   10g 
Peptone                                                       10g 
NaCl                                                            5g 
Distilled water                                            1000 ml  
 Blood agar:  
 Defibrinated blood                                   50ml 
 Nutrient agar                                            950 ml  
 Nutrient Broth  was gelled by addition of 2% agar. Sterilized by 
autoclaving at 121°C for 15 min. Then the blood was added at 40°C                           
Brain heart infusion broth (BHI): 
BHI                                                          37g 
D.W                                                         1000ml 
 The media were sterilized by autoclaving at 121°c for 15 min.  
 
 
 
 
 
 
 
 Appendix П 
Buffers:                                               
Normal saline: 
NaCl                                                       8.5g 
D.W                                                        1000ml 
The buffer was sterilized by autoclaving at 121°C for 15 min.                                        
Phosphate buffer saline:  
NaCl                                                         8g 
NaH2PO4                                                1.15g 
KH2PO4                                                  0.2g 
KCl                                                          0.2g 
D.W                                                        1000 ml   
   The pH was optimized to 7.2. 
0.1M phosphate buffer (PB), pH 7.8:- 
Sodium phosphate (NaH2PO4.H2O)                              52.4g 
Deionized water to final volume                                      3.8L 
The pH was adjusted to 7.8  
 
 
 
 
 
 
 
 
 
 
 Appendix III 
SDS PAGE Buffers: 
Running buffer: 
Tris-OH                                                   3.02g 
Glycine                                                   14.4g 
SDS                                                        1g 
800 ml of D.W was added pH was adjusted to 8.3 then completed to 
1000ml. 
Sample buffer: 
Tris- OH                                                 1ml 
Glycerol                                                  0.8ml 
SDS 10%                                                1.6ml  
2-mercapto-ethanol                                    0.4ml 
Bromophenol blue 0.05%                          0.2ml 
D.W                                                            4ml  
Staining buffer: 
GAA                                                           5.75ml 
Methanol                                                   28.5ml 
D.W                                                           62.5ml  
Coomassie brilliant blue                            0.157-0.2g 
De-staining solution: 
GAA                                                            10ml 
Methanol                                                      50ml 
D.W                                                             100ml 
 
 
 
 
 Appendix IV 
Western blotting buffers: 
Transfer Buffer: 
glycine                                                          14.4g 
Tris base                                                        3.02g 
Methanol                                                       100ml 
D.W                                                               900ml 
pH was Adjust to 8.3. 
Blocking buffer: 
Gelatin                                                  2g 
PBS                                                      100ml 
Gelatin was added to PBS and heated in water bath until dissolve 
Serum diluents: 
Gelatin                                                  1g 
PBS                                                       100ml 
Tween20                                                50 µl 
Gelatin was added to PBS and heated in water bath until dissolved. 
Then Tween20 was added. 
Preparation of primary antibody: 
Hyperimmune sera                               125 µl 
Serum diluent                                        25ml 
Preparation of conjugate: 
Anti rabbit conjugate                             25 µl 
Serum diluents                                       25ml 
Washing buffer: 
PBS                                                        250ml 
Tween20                                                125 µl 
Preparation of substrate: 
4. Chloro α. naphthol                             0.002g 
Methanol                                               5ml 
PBS                                                       25ml 
H2O2                                                      100 µl  
 
 Appendix V: 
PCR reagent: 
Tris boric EDTA Buffer (TBE):  
Tris base                                                  108 g 
Boric acid                                                55g 
0.5M EDTA (pH8.0)                               40 ml 
Stock 10x TBE 
Loading dye:  
Bromophenol blue (11%)                          10 µl 
Glycerol                                                     40 µl 
DDW                                                          50 µl 
 
 
